Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shenzhen Edge Medical CoFRA:R5Z -0.96%20 Receivables Turnover is 2.11 as of Dec. 2025. GuruFocus rates FRA:R5Z with a GF Score™ of 20/100. The stock has 3 warning signs investors should review. Among 813 Medical Devices & Instruments companies, Shenzhen Edge Medical Co ranks worse than 74.29% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Shenzhen Edge Medical Co's Revenue for the
six
months ended in Dec. 2025 was €37.14 Mil. Shenzhen Edge Medical Co's average Accounts Receivable for the
six
months ended in Dec. 2025 was €17.64 Mil.
Hence, Shenzhen Edge Medical Co's Receivables Turnover for the
six
months ended in Dec. 2025 was 2.11.
Shenzhen Edge Medical Co (FRA:R5Z) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Shenzhen Edge Medical Co Receivables Turnover Related Terms
Shenzhen Edge Medical Co Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Shenzhen Edge Medical Co's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhen Edge Medical Co Receivables Turnover Chart
Shenzhen Edge Medical Co Annual Data
Trend
Dec23
Dec24
Dec25
Receivables Turnover
2.81
4.93
3.43
Shenzhen Edge Medical Co Semi-Annual Data
Dec23
Jun24
Dec24
Jun25
Dec25
Receivables Turnover
0.00
1.76
2.70
2.30
2.11
FRA:R5Z vs ABT, SYK, MDT: Receivables Turnover Comparison
For the Medical Devices subindustry, Shenzhen Edge Medical Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shenzhen Edge Medical Co Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen Edge Medical Co's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Shenzhen Edge Medical Co's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhen Edge Medical Co (FRA:R5Z) has a Receivables Turnover of 2.11 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Shenzhen Edge Medical Co and its competitors. According to the industry distribution chart, Shenzhen Edge Medical Co ranks #604 out of 813 companies in the Medical Devices & Instruments industry, placing it in the top 74.3%.
Is Shenzhen Edge Medical Co's Receivables Turnover too high?
Shenzhen Edge Medical Co's current Receivables Turnover is 2.11. The Medical Devices & Instruments industry median Receivables Turnover is 5.60. Shenzhen Edge Medical Co's value of 2.11 is 62.3% below this industry median. Based on the distribution chart, Shenzhen Edge Medical Co ranks #604 out of 813 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Shenzhen Edge Medical Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Shenzhen Edge Medical Co's Receivables Turnover compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shenzhen Edge Medical Co ranks #604 out of 813 companies for Receivables Turnover. This places Shenzhen Edge Medical Co in the lower half of its industry. The industry median Receivables Turnover is 5.60. Shenzhen Edge Medical Co's value of 2.11 is 62.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.60, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shenzhen Edge Medical Co's current Receivables Turnover of 2.11 is 62.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Shenzhen Edge Medical Co and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shenzhen Edge Medical Co's current Receivables Turnover is 2.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Edge Medical Co stock overvalued right now?
Shenzhen Edge Medical Co (FRA:R5Z) has a current Receivables Turnover of 2.11. The current Receivables Turnover is 2.11 and 62.3% below the Medical Devices & Instruments industry median of 5.60. Shenzhen Edge Medical Co's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Shenzhen Edge Medical Co (FRA:R5Z), the current Receivables Turnover is 2.11 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Shenzhen Edge Medical Co Ltd is principally engaged in the designing, research and development, manufacturing and sale of surgical robots. It has a pipeline of three products and product candidates covering various models at different development stages to capture the market potential in surgical robots, including Edge Multi-Port Endoscopic Surgical Robot and Edge Single-Port Endoscopic Surgical Robot for MIS, as well as Edge Bronchoscope Robot for non-invasive surgery. The company derives revenue principally from the sales of surgical robot systems, instruments and accessories, and provision of services. Geographically, the maximum revenue is generated from the Chinese mainland, followed by Asia (other than Chinese Mainland), Europe, and Others.
20GF Score
Get the complete analysis for FRA:R5Z
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:R5Z has been successfully added to your 
